Illumina unveils first-of-its-kind spatial transcriptomics technology
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
TD Cowen Reiterates Hold Rating on Illumina (ILMN)
February 19, 2025 12:46 PM ESTTD Cowen analyst Dan Brennan reiterated a Hold rating and $140.00 price target on Illumina (NASDAQ: ILMN).
The analyst comments "ILMN unveiled a new spatial transcriptomics technology (sparse details) enabled directly on ILMN sequencers for unbiased whole-transcriptome profiling. We expect additional... More
